GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Optigenex Inc (OTCPK:OPGX) » Definitions » EBITDA Margin %

Optigenex (Optigenex) EBITDA Margin % : -107.10% (As of Jun. 2008)


View and export this data going back to 2004. Start your Free Trial

What is Optigenex EBITDA Margin %?

EBITDA Margin % is calculated as EBITDA divided by its Revenue. Optigenex's EBITDA for the three months ended in Jun. 2008 was $-0.20 Mil. Optigenex's Revenue for the three months ended in Jun. 2008 was $0.18 Mil. Therefore, Optigenex's EBITDA margin for the quarter that ended in Jun. 2008 was -107.10%.


Optigenex EBITDA Margin % Historical Data

The historical data trend for Optigenex's EBITDA Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Optigenex EBITDA Margin % Chart

Optigenex Annual Data
Trend Dec04 Dec05 Dec06 Dec07
EBITDA Margin %
-1,581.71 -2,052.52 -1,113.95 -254.72

Optigenex Quarterly Data
Sep04 Dec04 Mar05 Jun05 Sep05 Dec05 Mar06 Jun06 Sep06 Dec06 Mar07 Jun07 Sep07 Dec07 Mar08 Jun08
EBITDA Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -338.04 -152.98 -491.51 -93.85 -107.10

Competitive Comparison of Optigenex's EBITDA Margin %

For the Diagnostics & Research subindustry, Optigenex's EBITDA Margin %, along with its competitors' market caps and EBITDA Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Optigenex's EBITDA Margin % Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Optigenex's EBITDA Margin % distribution charts can be found below:

* The bar in red indicates where Optigenex's EBITDA Margin % falls into.



Optigenex EBITDA Margin % Calculation

EBITDA margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent.

Optigenex's EBITDA Margin % for the fiscal year that ended in Dec. 2007 is calculated as

EBITDA Margin %=EBITDA (A: Dec. 2007 )/Revenue (A: Dec. 2007 )
=-1.187/0.466
=-254.72 %

Optigenex's EBITDA Margin % for the quarter that ended in Jun. 2008 is calculated as

EBITDA Margin %=EBITDA (Q: Jun. 2008 )/Revenue (Q: Jun. 2008 )
=-0.196/0.183
=-107.10 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Optigenex  (OTCPK:OPGX) EBITDA Margin % Explanation

EBITDA Margin % is the ratio of EBITDA divided by net sales or Revenue. It is an performance metric measuring company's operating profitability. EBITDA Margin takes depreciation and amortization, interest expense and tax into account, which makes it easy to compare the relative profitability of companies of different sizes in the same industry.


Optigenex EBITDA Margin % Related Terms

Thank you for viewing the detailed overview of Optigenex's EBITDA Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.


Optigenex (Optigenex) Business Description

Traded in Other Exchanges
N/A
Address
901 Sam Rayburn Highway, Melissa, TX, USA, 75454
Optigenex Inc is an applied sciences company dedicated to solutions for healthy age management. The company offers AC-11, a powdered and bioactive rainforest plant extract that helps the body to repair sun and environmental stress-related damage to DNA, and slow down the process of skin aging.
Executives
Richard S Serbin director, 10 percent owner, officer: CEO, President & Secretary 750 LEXINGTON AVENUE, 6TH FLOOR, NEW YORK NY 10022

Optigenex (Optigenex) Headlines

No Headlines